Ligand validation:5KAI

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

SQD is a Ligand Of Interest in 5KAI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5KAI_SQD_A_612	39%	35%	0.206	0.918	0.96	1.67	5	12	0	0	96%	0.963
5KAI_SQD_a_714	37%	36%	0.217	0.918	0.95	1.63	5	12	0	0	100%	1
5KAI_SQD_B_626	24%	35%	0.25	0.882	0.95	1.71	5	10	0	0	100%	1
5KAI_SQD_b_601	19%	35%	0.238	0.831	0.94	1.72	3	10	0	0	100%	1
5KAI_SQD_A_614	16%	47%	0.223	0.837	0.88	1.2	2	3	0	0	74%	0.7407
5KAI_SQD_D_410	14%	34%	0.291	0.881	1.06	1.63	5	10	0	0	80%	0.7963
5KAI_SQD_f_102	11%	34%	0.301	0.866	1.09	1.6	5	9	0	0	76%	0.7593
5KAI_SQD_B_623	6%	31%	0.269	0.736	1.01	1.82	3	12	0	0	87%	0.8704
5KAI_SQD_I_102	1%	47%	0.485	0.648	0.86	1.22	2	2	0	0	74%	0.7407
5V2C_SQD_a_413	94%	24%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
6DHE_SQD_A_412	77%	23%	0.113	0.961	1.05	2.27	5	14	0	0	96%	0.963
8IRC_SQD_a_411	77%	32%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	75%	33%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1
8IRF_SQD_a_410	75%	32%	0.125	0.96	0.96	1.83	3	13	0	0	100%	0.49
8IR8_SQD_a_409	75%	33%	0.126	0.96	0.95	1.77	3	13	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.